Professionals

FREE SHIPPING ON ORDERS OVER £60 (UK)

Recommended products
noticias-datos-interes

Hifas da Terra receives the Nutraforum 2024 award for the best nutraceutical company

HIFAS DA TERRA RECIBE EL PREMIO NUTRAFORUM 2024 A LA MEJOR EMPRESA DE NUTRACÉUTICOS

3dids .com |

Hifas da Terra receives the Nutraforum 2024 award for the best nutraceutical company

 

  • On September 25, Hifas da Terra received the Nutraforum 2024 Award for the best nutraceutical company of Spain in the X edition of the Farmaforum Congress, which recognizes its leadership in the food supplements industry.
  • Hifas da Terra has the focus on the disruptive innovation addressed from a One Health perspective, seeking to meet the needs of the population with Safe and supported solutions for own scientific evidence.
  • Since 2021, Hifas Da Terra has seen an exponential growth in its sales outside the European Union, with an increase of more than 500%, which strengthen its international expansion.

 

 


Hifas da Terra has recently been awarded the Nutraforum 2024 Award for the best nutraceutical company, a recognition that highlights its innovative work and its commitment to the development of high quality nutraceutical products. Nutraberum is part of the most important national event of the pharmaceutical industry: Farmaforum.

Claudia Fernández, Innovation Hub Manager From the company, he received this distinction from Lois Fraiz Ares, director of Nutraforum, in an event that took place in the framework of the celebration of the tenth anniversary of the Farmaforum Congress, which was held in IFEMA. Eugenio Pérez de Lema Carmona, general director of Farmaforum; Eduardo Sanz Sánchez, director of the Farmaforum Congress and Marcos Muiños Docampo; Farmaforum commercial director also participated in this ceremony, which attracted more than 7200 industry professionals.


Growth of more than 500%

This recognition underlines the role of Hifas da Terra as leader in the Research and marketing of nutraceutics based on medicinal fungi. The company has demonstrated its ability to expand its international presence, with a Growth of more than 500% in its sales outside the European Union since 2021, as Claudia Fernández mentioned in his speech at the round table on opportunities in the export of food supplements during the event.
 
During Nutraforum 2024, the Hifas Da Terra Directive highlighted the importance of analyzing the profitability and viability of developing new products from the project conception stage, reviewing in depth the legality that can be applied to avoid temporary deviations and non -budgeted cost overruns.
 

Safe solutions supported by scientific evidence

"The most critical phases of the projects are undoubtedly the initials, in which we focus on analyzing the profitability and viability of the project. In the event that it implies a process of Novel Food, it would be necessary to contemplate the necessary investment for this process and the deadlines for the project to be economically viable and can reach the market within the established period," said Fernández, who took the opportunity to emphasize the Company's commitment to excellence in each phase of the process, from the initial investigation to the postcomercialization.

Beyond the EU

The increase in sales abroad explains in part the growth and expansion of Hifas da Terra. So, 10% of their total sales come from countries outside the EU. 

Fernández explained that growth in these markets has been exponential and stressed The importance of adapting to local regulations, tariff barriers and challenges derived from geopolitical tensions.

With this award, Hifas da Terra not only consolidates its position as leader in the nutraceutical sector, but also reinforces your commitment to innovation and sustainable development, Contributing to the advancement of health through science and biotechnology.

Los productos de la tienda online son complementos alimenticios que no previenen, tratan o curan alguna enfermedad humana y no reemplazan la atención o terapias médicas u otros medicamentos de prescripción.